Fluor CorporationFluor completed the largest capital project in CTA history and secured a new supply chain study contract with Voyageur Pharmaceuticals, indicating strong demand for its services.

Fluor Corporation has reached substantial completion on the Chicago Transit Authority Red and Purple Line Modernization project, the largest capital project in CTA history. The company has also been engaged by Voyageur Pharmaceuticals to conduct studies on a North American based pharmaceutical supply chain. These developments expand Fluor's activity across urban transit infrastructure and integrated pharmaceutical supply chains. Fluor shares are at $49.45 with a year-to-date return of 18.6% and a five-year return of 187.3%, though the stock is down 7.8% over the past week and 6.3% over the past year.
Fluor CorporationFluor completed the largest capital project in CTA history and secured a new supply chain study contract with Voyageur Pharmaceuticals, indicating strong demand for its services.
Voyageur Pharmaceuticals engaged Fluor to conduct a supply chain study, expanding its activity in pharmaceutical supply chains.